Accès gratuit
Numéro
Biologie Aujourd’hui
Volume 216, Numéro 3-4, 2022
Page(s) 125 - 130
DOI https://doi.org/10.1051/jbio/2022013
Publié en ligne 6 février 2023
  • Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA, 107, 4389-4394. [CrossRef] [PubMed] [Google Scholar]
  • Becker, J.A., Clesse, D., Spiegelhalter, C., Schwab, Y., Le Merrer, J., Kieffer, B.L. (2014). Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology, 39, 2049-2060. [CrossRef] [PubMed] [Google Scholar]
  • Carter, C.S., Getz, L.L. (1993). Monogamy and the prairie vole. Sci Am, 268, 100-106. [CrossRef] [PubMed] [Google Scholar]
  • Chini, B., Mouillac, B., Ala, Y., Balestre, M.N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard, S., Barberis, C. (1997). Identification of a single residue responsible for agonist selectivity in the Oxytocin–Vasopressin receptors. Ann NY Acad Sci, 812, 218-221. [CrossRef] [PubMed] [Google Scholar]
  • Danoff, J.S., Wroblewski, K.L., Graves, A.J., Quinn, G.C., Perkeybile, A.M., Kenkel, W.M., Lillard, T.S., Parikh, H.I., Golino, H.F., Gregory, S.G., Carter, C.S., Bales, K.L., Connelly, J.J. (2021). Genetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression. Clin Epigenetics, 13, 23. [CrossRef] [PubMed] [Google Scholar]
  • Frantz, M.C., Rodrigo, J., Boudier, L., Durroux, T., Mouillac, B., Hibert, M. (2010). Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist. J Med Chem, 53, 1546-1562. [CrossRef] [PubMed] [Google Scholar]
  • Frantz, M.C., Pellissier, L.P., Pflimlin, E., Loison, S., Gandía, J., Marsol, C., Durroux, T., Mouillac, B., Becker, J.A.J., Le Merrer, J., Valencia, C., Villa, P., Bonnet, D., Hibert, M. (2018). LIT-001, the first nonpeptide oxytocin receptor agonist that improves social interaction in a mouse model of autism. J Med Chem, 61, 8670-8692. [CrossRef] [PubMed] [Google Scholar]
  • Freund-Mercier, M.J., Ocytocine : entre mythe et réalité, Doin Ed., Paris, 2022. [Google Scholar]
  • Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., Hoflack, J. (1991). Three-dimensional models of the cationic neurotransmitter G-protein coupled receptors. Mol Pharmacol, 40, 8-15. [PubMed] [Google Scholar]
  • Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., Hoflack, J. (1993). This is not a G protein-coupled receptor. Trends Pharmacol Sci, 14, 7-12. [CrossRef] [PubMed] [Google Scholar]
  • Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Paquet, J.L., Leppik, R., Barberis, C., Mouillac, B., Chini, B., Jard, S. (1995). 3D models of hormone receptors: experimental validation. Eur J Med Chem, 30, 189-199. [Google Scholar]
  • Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Mouillac, B., Chini, B., Mahé, E., Cotte, N., Jard, S., Manning, M., Barberis, C. (1999). Functional architecture of vasopressin/oxytocin receptors. J Recept Signal Transduct Res, 19, 589-596. [CrossRef] [PubMed] [Google Scholar]
  • Hibert, M., Ocytocine mon amour, HumenSciences Ed., Paris, 2021. [Google Scholar]
  • Hicks, C., Ramos, L., Reekie, T., Narlavar, R., Kassiou, M., McGregor, L. (2015). WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology, 232, 2659-2667. [CrossRef] [PubMed] [Google Scholar]
  • Hilfiger, L., Zhao, Q., Kerspern, D., Inquimbert, P., Andry, V., Goumon, Y., Darbon, P., Hibert, M., Charlet, A. (2020). A nonpeptide oxytocin receptor agonist for a durable relief of inflammatory pain. Sci Rep, 10, 3017. [CrossRef] [PubMed] [Google Scholar]
  • Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C.M., Aronowitz, B.R. (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology, 28, 193-198. [CrossRef] [PubMed] [Google Scholar]
  • Karpenko, I.A., Margathe, J.F., Rodriguez, T., Pflimlin, E., Dupuis, E., Hibert, M., Durroux, T., Bonnet, D. (2015). Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay. J Med Chem, 58, 2547-2552. [CrossRef] [PubMed] [Google Scholar]
  • Meyerowitz, J., Robertson, M., Ximena Barros-Álvarez, X., Panova, O., Nwokonko, R., Gao, Y., Skiniotis, G. (2022). The oxytocin signaling complex reveals a molecular switch for cation dependence. Nat Struct Mol Biol, 29, 274-281. [CrossRef] [PubMed] [Google Scholar]
  • Mouillac, B., Chini, B., Balestre, M.N., Jard, S., Barberis, C., Manning, M., Tribollet, E., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M. (1995). Identification of agonist binding sites of vasopressin and oxytocin receptors. Adv Exp Med Biol, 395, 301-310. [PubMed] [Google Scholar]
  • Phalipou, S., Seyer, R., Cotte, N., Barberis, C., Hibert, M., Mouillac, B. (1999). Docking of linear peptide antagonists into the human V1a vasopressin receptor: identification of binding domains by photoaffinity. J Biol Chem, 274, 23316-23327. [CrossRef] [PubMed] [Google Scholar]
  • Pitt, G.R., Batt, A.R., Haigh, R.M., Penson, A.M., Robson, P.A., Rooker, D.P., Tartar, A.L., Trim, J.E., Yea, C.M., Roe, M.B. (2004). Nonpeptide oxytocin agonists. Bioorg Med Chem Lett, 14, 4585-4589. [CrossRef] [PubMed] [Google Scholar]
  • Rahman, Z., Resnick, L., Rosenzweig-Lipson, S.J., Ring, R.H. (2007). Methods of treatment using oxytocin receptor agonists. US patent application 2007/0117794 (published 2007-05-24). [Google Scholar]
  • Tahtaoui, C., Balestre, M.N., Klotz, P., Rognan, D., Barberis, C., Mouillac, B., Hibert, M. (2003). Identification of the binding sites of the SR 49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors. J Biol Chem, 278, 40010-40019. [CrossRef] [PubMed] [Google Scholar]
  • Trumpp-Kallmeyer, S., Bruinvels, J.A., Hibert, M. (1992) Modelling of G-protein coupled receptors: application to dopamine, serotonin, adrenaline, acetylcholine and mammalian opsin receptors. J Med Chem, 35, 3448-3462. [CrossRef] [PubMed] [Google Scholar]
  • Waltenspühl, Y., Schöppe, J., Ehrenmann, J., Kummer, L., Plückthun, A. (2020). Crystal structure of the human oxytocin receptor. Sci Adv, 15, 6, eabb5419. [CrossRef] [PubMed] [Google Scholar]
  • Williams, J.R., Insel, T.R., Harbaugh, C.R., Carter, C.S. (1994). Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol, 6, 247-250. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.